The Business of Medicine Channel

CEO of Onyx Pharmaceuticals on the Future of Drug Development

Forbes Healthcare Summit 2012

N. Anthony Coles, MD, President and CEO of Onyx Pharmaceuticals, discusses how developments in genomics and personalized medicine can pave the way for the future of drug development.

This interview was conducted at the Forbes Healthcare Summit 2012.

More in Business of Medicine

►

Physician Burnout: Addressing the Rapid Increase

Business of Medicine

Todd Unger, chief experience officer, AMA, and Christine Sinsky, MD, the AMA's vice president of professional satisfaction, discuss a recent study on physician burnout. Dr Sinsky explained that physician burnout...

► 23:10

MIT/CNC Future of Healthcare Conference 2021

Business of Medicine

For their 2021 Future of Healthcare & Medicine conference, the MIT Club of Northern California invited founders, technologists, investors, and industry leaders who are working to build the future of...

► 46:38

MIT/CNC Future of Healthcare Panel: Ending COVID-19 – From Ideas to Collective Action

Business of Medicine

Panelists discuss the progress and partnerships made by pharmaceutical companies, government, academia, and investors in the fight to control and end the pandemic, and offer ideas on how others can...

► 13:36

MIT/CNC Future of Healthcare Panel: Introduction & Fireside Chat

Business of Medicine

Members of the MIT Club of Northern California kickoff the 2021 Future of Healthcare conference in this panel discussion featuring speakers: Noubar Afeyan – Founder & CEO of Flagship Pioneering...